Perfusion is an integral part of your hospital’s cardiovascular care program, but the overhead costs and administrative burden of maintaining and managing a team of reliable perfusionists with advanced skills can pose challenges for program administrators. It can be easy, however, to overlook both the indirect costs and benefits of clinical services. So, whether your perfusion is handled in-house or outsourced, we’ve developed a new guide, The Real Spend of Your Perfusion Program: Twelve Tips to Discover the True Value, to help you evaluate your program and any changes that you might be considering.
AORN 2017 was the place to be for perioperative registered nurses and others who share a continuing commitment to quality care. Nurses, and the hospitals they represent, are constantly looking for ways to improve patient outcomes while also reducing the cost of care. Both of these goals were addressed in some of the most talked-about educational sessions and posters presented during the conference. Cost containment and better clinical outcomes were also recurring themes among the 600 attendees who visited our booth. In addition to exhibiting, we hosted an educational networking dinner that featured a presentation on one of healthcare’s hottest topics—patient blood management (PBM).
A complex system offers a lot of places to hide bad behavior. Medicare and Medicaid—programs at the heart of the current healthcare debate—are particularly vulnerable to violations of Stark Law, the Anti-Kickback Statute, and the False Claims Act. Nearly every day, the Office of Inspector General (OIG) issues details of individuals and hospitals being charged or convicted of healthcare fraud and abuse. Financial penalties and the possibility of imprisonment aside, damning headlines can destroy the bottom line and reputation of even the most respected providers. Compliance violations drive up healthcare costs and compromise patients who are overcharged or subjected to unnecessary tests and treatments.
Collaborating and sharing research findings and best practices with other medical professionals is one of the great pleasures of working in healthcare. Recently, the American Academy of Cardiovascular Perfusion’s 38th International Meeting gave SpecialtyCare’s Medical Office team members the opportunity to present two new papers to the perfusion community. One of the studies examines “The Effect of Ultrafiltration on End-Cardiopulmonary Bypass Hematocrit during Cardiac Surgery.” The purpose of this research was to evaluate the effect of ultrafiltration on end-cardiopulmonary bypass hematocrit by cardiac surgical procedure type. The findings are summarized in today’s blog.
Recently I attended the 2017 Annual Meeting of The American Academy of Cardiovascular Perfusion. The AACP, as always, offered strong educational content and a great opportunity to meet up with friends and colleagues. While there, I had the pleasure of presenting co-authored research on “The Effectiveness of Acute Normovolemic Hemodilution and Autologous Prime on Intraoperative Blood Management during Cardiac Surgery.” The AACP honored our team, which includes our perfusion associates and their tireless dedication to clinical excellence and data collection, by selecting this work as the meeting’s Best Paper. I encourage you to read the abstract for additional detail, but here’s a summary of our findings, which highlight the value of thoughtful perfusion strategies that can reduce the need for costly transfusions and increase the likelihood of better clinical outcomes.
Changes in reimbursement models are driving changes in operations, including data collection and reporting. Providers are being encouraged and incentivized to implement value-based care (VBC) that emphasizes cost savings and quality outcomes instead of the traditional fee-for-service (FFS) reimbursement model that pays according to the number of procedures performed. The idea is that when hospitals have financial incentives to be accountable for patient outcomes, then the comprehensive focus on quality will result in overall lower costs. Transitioning from FFS to VBC may be especially difficult for ORs with their high costs of procedures, but several strategies can help clear the path to progress.
Ultrafiltration is thought to reduce morbidity and the risk of red blood cell transfusion, however very few studies have examined the relationship between ultrafiltration and the overall risk of intraoperative RBC transfusion. Using data from the SpecialtyCare Operative Procedural Registry (SCOPE™), our study looks at a population of nearly 98,000 adults undergoing cardiac surgery at 197 hospitals to evaluate the effects of ultrafiltration volume removed during CPB on the relative risk of receiving an intraoperative RBC transfusion. Recognizing the findings of our own previous work, we were especially interested in testing potential differences between male and female patients in the effects of ultrafiltration.
The mission of The Joint Commission (TJC) is “to continuously improve health care for the public, in collaboration with other stakeholders, by evaluating health care organizations and inspiring them to excel in providing safe and effective care of the highest quality and value.” It’s a lofty goal, and one that has helped thousands of healthcare organizations improve. Unfortunately, the prospect of a TJC review is stressful and overwhelming for many healthcare providers. It doesn’t have to be. Check out these three things we’ve learned by designing and implementing a tested program that ensures that the people of our organization are always prepared to pass a stringent TJC evaluation while also meeting the requirements of our own internal quality programs.
It is a fairly well-known fact in the cardiac community that women have higher morbidity and mortality associated with coronary artery bypass (CABG) procedures. The reasons traditionally given for this disparity include women’s relatively smaller vasculature, higher incidence of anemia, and smaller circulating blood volume. Early in 2016, we in the Medical Department were discussing this phenomenon and decided to design a study using the robust data from our SpecialtyCare Operative Procedural Registry to find something in the intraoperative space that might be leading to these very different post-operative outcomes for men and women. Our findings were somewhat surprising.
The role of an expert IONM team is critical in the timely identification of adverse neurophysiologic changes and in promoting corrective action by the surgeon and anesthesiologist. Our research is based on clinical IONM data from SpecialtyCare’s Operative Procedural Registry. Taking advantage of big data—nearly 70,000 cases in this study—ensures that our conclusions are statistically significant, a vital aspect of evidence-based improvement in healthcare. It was an honor to present this study to such a prestigious group of surgeons at NASS and, in doing so, provide actionable information to help elevate the quality of care across the country.